Human Gene Therapy

Papers
(The median citation count of Human Gene Therapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation115
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid92
AVLAYAH and KRESLADI Win FDA Accelerated Approvals80
Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell Disease65
PASTE, Don't Cut: Genome Editing Tool Looks Beyond CRISPR and Prime56
Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future55
Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies47
Intra-Articular Delivery of an AAV-Anti-TNF-α Vector Alleviates the Progress of Arthritis in a RA Mouse Model45
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II42
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases40
SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential36
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study34
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian Hamsters34
SNAC: A Single-Nuclei Atlas of Capsid Distribution in Nonhuman Primate Eye34
Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis34
Adeno-Associated Virus-Mediated Interleukin-12 Gene Expression Alleviates Lung Inflammation and Type 2 T-Helper-Responses in Ovalbumin-Sensitized Asthmatic Mice33
Abstracts31
Meta-Analysis and Optimization of the In Vitro Immortalization Assay for Safety Assessment of Retroviral Vectors in Gene Therapy31
Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis30
Characterizing Complex Populations of Endogenous Adeno-Associated Viruses by Single-Genome Amplification30
uniQure Gene Therapy Significantly Slows Huntington Disease Progression30
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell30
Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop29
Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases28
Advancing Precision Medicine with Gene and Cell Therapy in Malaysia: Ethical, Legal, and Social Implications28
Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders27
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature26
Suppression of CNS APOE4 Expression by miRNAs Delivered by the S2 AAVrh.10 Capsid-Modified AAV Vector24
Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management24
Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta )23
Metagenomic Reconstruction of Adeno-Associated Virus Genomes22
CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells22
Quantitation of Residual Host Cell DNA in Recombinant Adeno-Associated Virus Using Droplet Digital Polymerase Chain Reaction22
Lived Experience with Gene Therapy21
Modulation of AAV9 Galactose Binding Yields Novel Gene Therapy Vectors and Predicts Cross-Species Differences in Glycan Avidity21
Correction to: An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature, by Ramirez et al. 21
Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for Sensitive Analysis of Residual Protein Tat Bh1–101 in Lentiviral Vectors for Gene Therapy21
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors19
Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver19
Update on Viral Gene Therapy Clinical Trials for Retinal Diseases19
SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis19
Interview with Dr. Ronald Crystal18
Patient Dies in Beam Trial of Sickle Cell Disease Candidate; Company Cites Conditioning18
An Overview of the Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy18
A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response18
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Human Gene Therapy18
Intrastriatal Delivery of a Zinc Finger Protein Targeting the Mutant HTT Gene Allele Obviates Lipid Phenotypes in Brain and Plasma in Huntington's Disease Mice17
Adeno-Associated Virus-Mediated Gene Transfer of Inducible Nitric Oxide Synthase to an Animal Model of Pulmonary Hypertension17
Prediction of Adeno-Associated Virus Fitness with a Protein Language-Based Machine Learning Model17
Transduction of Ferret Surface and Basal Cells of Airways, Lung, Liver, and Pancreas via Intratracheal or Intravenous Delivery of Adeno-Associated Virus 1 or 616
Progress in Respiratory Gene Therapy16
Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study16
An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants16
Urocortin 2 Gene Transfer for Systolic and Diastolic Dysfunction Due to Chronically Increased Left Ventricular Pressure16
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles16
The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy15
Introduction to ESGCT 2024 Special Issue15
Onasemnogene Abeparvovec in Type 1 Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis14
Development and Delivery of a Hands-On Short Course in Adeno-Associated Virus Manufacturing to Support Growing Workforce Needs in Gene Therapy14
Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond13
Long-Term Follow-Up of Patients Receiving Cell and Gene Therapy Products13
Adeno-Associated Virus Type 9-Mediated Gene Therapy of Choline Acetyltransferase-Deficient Mice13
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-13
Chemical Epigenetic Regulation of Adeno-Associated Virus Delivered Transgenes13
Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma13
Effects of Urocortin 2 Gene Transfer on Glucose Disposal in Insulin-Resistant db/db Mice on Metformin13
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article12
Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing12
Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency12
Liver Gene Therapy12
Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 Disease12
Engineered Human Adenoviruses of Species B and C Report Early, Intermediate Early, and Late Viral Gene Expression12
Process Development of Recombinant Adeno-Associated Virus Production Platform Results in High Production Yield and Purity12
Akouos, Immusoft Win FDA Clearances for First-of-Their-Kind Gene Therapies12
Production of Recombinant Adeno-Associated Virus Through High-Cell-Density Transfection of HEK293 Cells Based on Fed-Perfusion Culture12
Leveraging CRISPR-Cas9 for Accurate Detection of AAV-Neutralizing Antibodies: The AAV-HDR Method12
Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMD12
Pfizer Weighs Next Steps after DMD Therapy Linked to Boy’s Death Fails Phase III Trial12
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer11
A Tripartite AAV System with Engineered Lox Sites Enables Efficient Delivery of the EYS Gene for Retinal Gene Therapy11
Acknowledgment of Reviewers 202511
Lilly, Seamless Ink Up-to-$1.12B Hearing Loss Collaboration11
Targeted E3 Region Engineering Boosts Antitumor Efficacy of Conditionally Replicating Adenoviruses in an Immunocompetent Tumor Model11
Exploring Development Options of a Polishing Chromatography Step for AAV7 and AAV811
Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C110
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse Model10
CRISPR-Cas Genome Editing in Ex Vivo Human Lungs to Rewire the Translational Path of Genome-Targeting Therapeutics10
A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies10
Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination10
A Modified Arrestin1 Increases Lactate Production in the Retina and Slows Retinal Degeneration10
Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy10
Hemophilia Gene Therapy: The End of the Beginning?10
Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells10
Improving Molecular and Histopathology in Diaphragm Muscle of the Double Transgenic ACTA1-MCM/FLExDUX4 Mouse Model of FSHD with Systemic Antisense Therapy10
Efficient Delivery of Adeno-Associated Virus into Inner Ear In Vivo Through Trans-Stapes Route in Adult Guinea Pig10
Progress, Applications and Prospects of CRISPR-Based Genome Editing Technology in Gene Therapy for Cancer and Sickle Cell Disease9
Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose9
Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis9
Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing9
A Paradox of the Field's Own Success: Unintended Challenges in Bringing Cutting-Edge Science from the Bench to the Market9
Marks’ Resignation Sparks Concerns on FDA Regulation of Gene Therapies9
Adeno-Associated Virus-Mediated Knockdown of Agmatinase Attenuates Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Colorectal Cancer9
Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?9
Stable and Predictable Lentiviral Vector Production at Clinical Scale9
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67 phox -Deficient Chronic Granulomatous Disease9
Personalizing Oncolytic Virotherapy9
The Future of Exon Skipping for Duchenne Muscular Dystrophy9
Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs9
Interview with Barry Byrne, MD/PhD9
The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis9
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells8
The 2024 Nobel Prize: Impact of the Discovery of miRNA on the Field of Gene Therapy8
A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions8
AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys8
The Coming of Age of Gene Therapy for the Treatment of Human Diseases: A Regulatory Perspective8
Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges8
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration8
Medicinal Products Based on Adeno-Associated Viral Vectors: A Regulatory Perspective on the Potential Risk of Insertion-Mediated Tumorigenesis8
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations8
Correction to: Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatm8
ESGCT 29th Annual Congress In collaboration with BSGCT Edinburgh, UK October 11–14, 2022 Abstracts8
Intracisternal AAV9-MAG- hABCD1 Vector Reverses Motor Deficits in Adult Adrenomyeloneuropathy Mice8
Long-Term Functional Correction of Pompe Disease and Increased α-Glucosidase Expression after Gene Therapy with Novel Combinations of Muscle-Targeted Transcriptional Cis 8
Ultragenyx Gene Therapies Spark Lawsuit from Lacks Family8
Safe and Efficacious Permanent Removal of Large COL7A1 Exons for Gene Reframing as a Reliable Therapeutic Strategy for Recessive Dystrophic Epidermolysis Bullosa8
CRISPR in Medicine: A Systematic Review of Clinical Trials and Therapeutic Applications7
Gene Therapy for Immunoglobulin E, Complement-Mediated, and Eosinophilic Disorders7
Akouos Therapy Restores 11-Year-Old Boy's Hearing After 1 Month7
FDA Investigating Sarepta’s Elevidys® after Second Patient Dies7
MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β17
Quantification of Linear Polyethylenimines in Recombinant Adeno-Associated Virus by High-Performance Liquid Chromatography with Charged Aerosol Detection7
Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats–Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency7
Blood Cancers Reported in Seven Children Dosed with SKYSONA™7
Timely Intervention: Navigating Ethical Challenges in OTOF -Gene Therapy Trials7
Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein7
Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Human Gene Therapy7
HIV Tat-Conjugated Histone H3 Peptides Induce Tumor Cell Death Via Cellular Stress Responses7
Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair7
Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model7
USP7-SOX9-miR-96-5p-NLRP3 Network Regulates Myocardial Injury and Cardiomyocyte Pyroptosis in Sepsis7
Remembrances of Kenneth Berns, PhD6
Interview with Dr. David Williams6
Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer6
Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression6
AAV-p40 Bioengineering Platform for Variant Selection Based on Transgene Expression6
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain6
The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in China6
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver Transduction6
Heart of the Matter: AAV8 Improves Cardiac Function6
Construct Optimization Enables Oncolytic Virus-Mediated Functional Membrane Localization of Calreticulin and Macrophage Reprogramming6
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD6
Immune Responses to Muscle-Directed Adeno-Associated Viral Gene Transfer in Clinical Studies6
Lipid Nanoparticle-Delivered mRNA Therapy Corrects Neonatal Murine MPS I-H6
A Review of the Legislation of Direct-to-Consumer Genetic Testing in China6
Suicide Gene Delivery System Mediated by Ultrasound-Targeted Microbubble Destruction: A Promising Strategy for Cancer Therapy6
International Conference on Lymphocyte Engineering Author Index6
Call for Papers: Special Issue on Toxicity And Safety in Clinical AAV Gene Therapy5
Acknowledgment of Reviewers 20225
Remembrances of Nicholas Muzyczka, PhD5
Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing5
Hospital Exemption for Advanced Therapy Medicinal Products in Spain5
An Engineered Adeno-Associated Virus Variant Enables Efficient Gene Editing in Human T Cells5
Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease5
Concise Analysis of Single-Stranded DNA of Recombinant Adeno-Associated Virus By Automated Electrophoresis System5
Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction5
Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA Mice5
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice5
Autologous Production: The Future of Sustainable Antibody Treatments5
Developing Gene Therapy for Mitigating Multisystemic Pathology in Fabry Disease: Proof of Concept in an Aggravated Mouse Model5
Acknowledgment of Reviewers 20235
Lentiviral Gene Delivery Rescues Ciliary Defects in Patient-Derived Airway Organoids from Primary Ciliary Dyskinesia5
Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors5
An Analysis of Biomarkers for the Evaluation of Gene Therapy in Niemann–Pick Disease Type C1 Mice5
Bone Marrow Mesenchymal Stem Cell-Derived Exosomes microRNA-31-5p Repress Pulmonary Fibrosis via IGFBP75
Vertex, Enlaza Launch Up-to-$2B Collaboration to Improve CASGEVY® Conditioning5
Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases5
The Lived Experience of Pediatric Gene Therapy: A Scoping Review4
Pharmacokinetic and Pharmacodynamic Evaluation of Bidridistrogene Xeboparvovec in an Aged Murine Model of Limb-Girdle Muscular Dystrophy Type 2E/R44
Recombinant Adeno-Associated Virus Vector Mediated Gene Editing in Proliferating and Polarized Cultures of Human Airway Epithelial Cells4
Regeneron Wins FDA Approval for First Neurosensory Gene Therapy4
Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral Immunity4
Strategies and Advances in Site-Specific Integration of Exogenous Large Genes4
Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment4
Interview with Dr. Florian Eichler4
Comparison of Physical Perturbation Devices for Enhancing Lentiviral Vector-Mediated Gene Transfer to the Airway Epithelium4
Correction to: Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors, by Westhaus et al. 4
How Great a Risk Do You Take? A Qualitative Study Exploring Attitudes of Individuals with Friedreich Ataxia Toward Gene Therapy4
Verve Pauses Enrollment in Base Editing Trial after Adverse Events4
Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy4
Improvement of Precision in Recombinant Adeno-Associated Virus Infectious Titer Assay with Droplet Digital PCR as an Endpoint Measurement4
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors4
Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation4
Precision BioSciences, Novartis Launch Up-to-$1.5B In Vivo Genome Editing Collaboration4
FDA Issues Plausible Mechanism Pathway Draft Guidance4
Quantification of Lentiviral Vectors with Nucleic Acid Dyes4
First Prime Editing Clinical Trial Expected in 20244
Food and Drug Administration Sets Stage for Approval of First Duchenne Muscular Dystrophy Gene Therapy4
Interlaboratory Measurement of Adeno-Associated Virus: Comparative Quantification of Full and Empty Capsids4
Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches4
Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors4
Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells4
Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors4
Cure Rare Disease: An Initiative to Enable N of 1 Gene Editing4
International Conference on Lymphocyte Engineering September 12–14 2023 Munich, Germany4
Call for Special Issue Papers: Genetic and Nongenetic Inflammation Networks in Major Human Diseases4
Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors4
Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case3
Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases3
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 13
Prevalent and Disseminated Recombinant and Wild-Type Adeno-Associated Virus Integration in Macaques and Humans3
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy3
Cyclosporin H Improves the Transduction of CD34 + Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease3
Prevention of Portal-Tract Fibrosis in Zfyve19 −/− Mouse Model with Adeno-As3
Innate Immune Sensing of Adeno-Associated Virus Vectors3
Preclinical Safety and Biodistribution in Mice Following Single-Dose Intramuscular Inoculation of Tumor DNA Vaccine by Electroporation3
Roche, Ascidian Launch Up-to-$1.8B RNA Exon Editing Collaboration3
Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome3
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments3
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of Neurodegeneration3
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy3
Kallistatin Improves High-Fat-Induced Insulin Resistance via Epididymal Adipose Tissue-Derived Exosomes3
Sarepta Pauses, then Resumes, Shipments of DMD Gene Therapy3
Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease3
Letter to the Editor: mRNA Vaccines in Urological Malignancies3
Correction to: Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice, by Xiao et al. Hum Gene Ther3
Efficient Gene Transfer to Kidney Using a Lentiviral Vector Pseudotyped with Zika Virus Envelope Glycoprotein3
Beam Results Show First Genetic Correction of Disease-Causing Mutation3
Correction to: Efficacy and Safety of Adeno-Associated Virus-Based Clinical Gene Therapy for Hemophilia: A Systematic Review and Meta-Analysis, by Han et al. 3
Case Study Cites Immune Reaction to High Adeno-Associated Virus Dose in Explaining Duchenne Muscular Dystrophy Trial Death3
Patient Dies after Treatment with Intellia CRISPR Therapy in Phase III Trial3
Single-Dose Intrathecal Dorsal Root Ganglia Toxicity of Onasemnogene Abeparvovec in Cynomolgus Monkeys3
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy3
ESGCT 32nd Annual Congress In collaboration with SETGYC Seville, Spain October 7-10, 2025 Abstracts3
Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy3
Current Status and Prospects of Viral Vector-Based Gene Therapy to Treat Kidney Diseases3
Advances in Off-Target Detection for CRISPR-Based Genome Editing3
Focused Ultrasounds as an Adeno-Associated Virus Gene Therapy-Empowering Tool in Juvenile Mice via Intracerebroventricular Administration3
Abstract Author Index3
0.56447005271912